Apr 8, 2020

THE.WAVE.TALK , a Seoul, South Korea-based developer of live bacteria sensing and IoT water turbidity test technology, raised USD2m in funding. This brought its accumulated total to approximately US$6m in funding. Existing investors include Bluepoint Partners, Naver, EstechPharma, and LB Investment (previously LG fund). The company intends to use the funds to continue to develop its product, constructing a big data network that automatically measures the water quality of ordinary households through an IoT sensor, and expand into the global market. Led by CEO Kim Young-dug Kim, THE.WAVE.TALK has developed its own live bacteria sensing and IoT water turbidity test technology, which will allow for speedy antibiotic susceptibility testing (AST) and minimum inhibitory concentration (MIC) testing at hospitals (in developing countries) with equipment that costs just several hundreds of USD. Currently, the company is working with four major local governments to complete a testbed by June that utilizes an IoT sensor to automatically test the most important factor of water quality, in turbidity, in homes. THE.WAVE.TALK will also be working on gaining certification from Good Manufacturing Practice (GMP) and Korea’s Ministry of Food and Drug Safety on antibiotic inspection equipment (such as “Bacometer AI” that can diagnose urinary tract infection in under 3 hours, and AST/MIC in under 6 hours). FinSMEs